Clinical outcome and plasma levels of clozapine and norclozapine in drug-resistant schizophrenic patients

Author： Mauri M.C. Volonteri L.S. Fiorentini A. Invernizzi G. Nerini T. Baldi M. Bareggi S.R.

Publisher： Elsevier

ISSN： 0920-9964

Source： Schizophrenia Research, Vol.66, Iss.2, 2004-02, pp. : 197-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Beneficial effect of the addition of the 5-HT 2A/2C and 2 antagonist mianserin to ongoing haloperidol treatment in drug-resistant chronically hospitalized schizophrenic patients

By Grinshpoon A. Valevski A. Moskowitz M. Weizman A.

European Psychiatry, Vol. 15, Iss. 6, 2000-09 ,pp. : 388-390

Elsevier

Access to resources Recommend Favorite

Sulpiride adjunction to clozapine in treatment-resistant schizophrenic patients: a preliminary case series study

By Shiloh R. Zemishlany Z. Aizenberg D. Weizman A.

European Psychiatry, Vol. 12, Iss. 3, 1997-01 ,pp. : 152-155

Elsevier

Access to resources Recommend Favorite

The clinical use of plasma clozapine levels in a maximum security setting

By Bennett Daniel Bremner Margaret Gray Colin

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 228-234

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical aspects and biological bases of drug-resistant epilepsies

By Regesta G. Tanganelli P.

Epilepsy Research, Vol. 34, Iss. 2, 1999-04 ,pp. : 109-122

Elsevier

Access to resources Recommend Favorite

Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients

By La Y. J. Wan C. L. Zhu H. Yang Y. F. Chen Y. S. Pan Y. X. Feng G. Y. He L.

Journal of Neural Transmission, Vol. 114, Iss. 5, 2007-05 ,pp. : 657-663

Springer Publishing Company

Access to resources Recommend Favorite